Fol. Biol. 2012, 58, 238-245
https://doi.org/10.14712/fb2012058060238
Recombinant Probiotic Therapy in Experimental Colitis in Mice
References
1. , F. E. (2003) Genetically modified probiotics in foods. Trends Biotechnol. 21, 491-497.
<https://doi.org/10.1016/j.tibtech.2003.09.006>
2. , I. F., Strain, J. J. (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal. Biochem. 239, 70-76.
<https://doi.org/10.1006/abio.1996.0292>
3. , R., Fedorak, R. N., Tannock, G. W., Madsen, K. L., Gionchetti, P., Campieri, M., De Simone, C., Sartor, R. B. (2005) VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am. J. Gastroenterol. 100, 1539-1546.
<https://doi.org/10.1111/j.1572-0241.2005.41794.x>
4. , A. C., Doe, W. F., Buffinton, G. D. (1999) Protein carbonyl formation on mucosal proteins in vitro and in dextran sulfate-induced colitis. Free Radic. Biol. Med. 27, 262-270.
<https://doi.org/10.1016/S0891-5849(99)00065-9>
5. , H., Rottiers, P., Hommes, D. W., Huyghebaert, N., Remaut, E., Remon, J. P., van Deventer, S. J., Neirynck, S., Peppelenbosch, M. P., Steidler, L. (2006) A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn’s disease. Clin. Gastroenterol. Hepatol. 4, 754-759.
<https://doi.org/10.1016/j.cgh.2006.03.028>
6. , B., Lodinová-Žádníkova, R., Enders, C., Sonnenborn, U., Schulze, J., Tlaskalová-Hogenová, H. (2002) Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand. J. Immunol. 55, 204-209.
<https://doi.org/10.1046/j.1365-3083.2002.01005.x>
7. , R., Barollo, M., Scarpa, M., Grillo, A. R., Brun, P., Vettorato, M. G., Castagliuolo, I., Sturniolo, G. C. (2011) Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis. Dig. Dis. Sci. 56, 1178-1187.
<https://doi.org/10.1007/s10620-010-1384-1>
8. , M., Schrezenmeir, J. (2008) Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 111, 1-66.
9. , O. (2004) A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin. Biochem. 37, 277-285.
<https://doi.org/10.1016/j.clinbiochem.2003.11.015>
10. , B., Dessein, R., Marceau, M., Poiret, S., Chamaillard, M., Pot, B., Simonet, M., Daniel, C. (2007) Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein. Gastroenterology 133, 862-874.
<https://doi.org/10.1053/j.gastro.2007.06.018>
11. Food and Agriculture Organization of the United Nations, WHO (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. In: Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. (http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf)
12. , S., Tatsuguchi, A., Gudis, K., Kishida, T., Mitsui, K., Ehara, A., Kobayashi, T., Sekita, Y., Seo, T., Sakamoto, C. (2007) High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease. J. Gastroenterol. Hepatol. 22, 1199-120.
<https://doi.org/10.1111/j.1440-1746.2006.04535.x>
13. , M. S., Butler, R. N., Giffard, P. M., Howarth, G. S. (2007) Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats. Int. J. Food Microbiol. 114, 267-274.
<https://doi.org/10.1016/j.ijfoodmicro.2006.09.018>
14. , A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D. C., Erckenbrecht, J., Raupach, B., Sonnenborn, U., Eckert, J., Schumann, R. R., Wiedenmann, B., Dignass, A. U., Sturm, A. (2006) Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2and toll-like receptor 4-dependent pathways. Infect. Immun. 74, 4075-4082.
<https://doi.org/10.1128/IAI.01449-05>
15. , J., Laass, M., Blokhin, B. M., Bolbot, Y. K., Maydannik, V. G., Elze, M., Wolff, C., Schulze, J. (2007) The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur. J. Pediatr. 166, 311-318.
<https://doi.org/10.1007/s00431-007-0419-x>
16. , M., D’Souza, A. L., Muthu, N., Rogers, T. R., Want, S., Rajkumar, C., Bulpitt, C. J. (2007) Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 335, 80.
<https://doi.org/10.1136/bmj.39231.599815.55>
17. , I. L., Snoeck, V., de Creus, A., Braat, H., De Jong, E. C., Van Deventer, S. J., Rottiers, P. (2007) Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin. Gastroenterology 133, 517-528.
<https://doi.org/10.1053/j.gastro.2007.04.073>
18. , H. Q., deBruyn, J., Guan, L., Diaz, H., Li, M., Girgis, S., Turner, J., Fedorak, R., Madsen, K. (2009) Probiotic preparation VSL#3 induces remission in children with mild to moderate acute ulcerative colitis: a pilot study. Inflamm. Bowel Dis. 15, 760-768.
<https://doi.org/10.1002/ibd.20816>
19. , A., Shima, T., Kato, K., Mizuno, S., Uehara, T., Matsumoto, S., Setoyama, H., Hara, T., Umesaki, Y. (2008) Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J. Gastroenterol. 14, 2511-2516.
<https://doi.org/10.3748/wjg.14.2511>
20. , H., Backer, J., Diaz, H., Yeung, H., Thiel, D., McKaigney, C., De Simone, C., Madsen, K. (2004) DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126, 1358-1373.
<https://doi.org/10.1053/j.gastro.2004.02.003>
21. , W., Fric, P., Pokrotnieks, J., Lukas, M., Fixa, B., Kascak, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., Wolff, C., Schulze, J. (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 1617-1623.
<https://doi.org/10.1136/gut.2003.037747>
22. , H., Leschner, S., Endmann, A., Westphal, K., Wolf, K., Kochruebe, K., Miloud, T., Altenbuchner, J., Weiss, S. (2009) Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes Infect. 11, 1097-1105.
<https://doi.org/10.1016/j.micinf.2009.08.002>
23. Baroja, M., Kirjavainen, P. V., Hekmat, S., Reid, G. (2007) Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin. Exp. Immunol. 149, 470-479.
<https://doi.org/10.1111/j.1365-2249.2007.03434.x>
24. , O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
<https://doi.org/10.1016/S0021-9258(19)52451-6>
25. , H., Krummenerl, T., Giensch, M., Wolff, C., Schulze, J. (2010) Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement. Altern. Med. 10, 13.
<https://doi.org/10.1186/1472-6882-10-13>
26. , A., Coatrieux, C., Ingueneau, C., Salvayre, R. (2008) Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J. Pharmacol. 153, 6-20.
<https://doi.org/10.1038/sj.bjp.0707395>
27. , K. A., Bartrow, M., Roeger, B., Moll, H., Sonnenborn, U., Oelschlaeger, T. A. (2009) Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88. Int. J. Med. Microbiol. 299, 467-478.
<https://doi.org/10.1016/j.ijmm.2009.03.003>
28. , G., Tsubouchi, R., Okayama, M., Kato, S., Mozsik, G., Takeuchi, K. (2004) Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Dig. Dis. Sci. 49, 1466-1472.
<https://doi.org/10.1023/B:DDAS.0000042248.48819.ad>
29. , M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F., Fellermann, K. (2007) Induction of human β-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 75, 2399-2407.
<https://doi.org/10.1128/IAI.01563-06>
30. , L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., Remaut, E. (2000) Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289, 1352-1355.
<https://doi.org/10.1126/science.289.5483.1352>
31. , L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J. P., Remaut, E. (2003) Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nat. Biotechnol. 21, 785-789.
<https://doi.org/10.1038/nbt840>
32. , A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., Modeo, M. E., Rodino’, S., D’Amico, S., Sebkova, L., Sacca’, N., Di Giulio, E., Luyya, F., Imeneo, M., Larussa, T., Di Rosa, S., Annese, V., Danese, S., Gasbarrini, A. (2010) Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am. J. Gastroenterol. 105, 2218-2227.
<https://doi.org/10.1038/ajg.2010.218>
33. , S., Gionchetti, P., D’Alo, S., Russo, F. P., Pesce, I., Ricci, G., Rizzello, F., Helwig, U., Cifone, M. G., Campieri, M., De Simone, C. (2001) Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am. J. Gastroenterol. 96, 2691-2699.
<https://doi.org/10.1111/j.1572-0241.2001.04139.x>
34. , A., Ferdinande, L., Neirynck, S., Rottiers, P., De Vos, M., Steidler, L., Cuvelier, C. A. (2008) Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice. Inflamm. Bowel Dis. 14, 471-479.
<https://doi.org/10.1002/ibd.20346>
35. , A. M., Gunzer, F., Deppenmeier, S., Tapadar, D., Hunger, J. K., Schmidt, M. A., Buer, J., Bruder, D. (2005) Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules. FEMS Immunol. Med. Microbiol. 43, 373-384.
<https://doi.org/10.1016/j.femsim.2004.10.023>
36. , S., Nordgaard, I., Hansen, U., Brockmann, E., Rumessen, J. J. (2011) A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis. J. Crohn’s Colitis 5, 115-121.
<https://doi.org/10.1016/j.crohns.2010.11.004>
37. , D. M., Crowther, P. J., Doherty, J., Jefferson, S., DeCruz, E., Noyer-Weidner, M., Smith, S. S., Michael, M. Z., Graham, M. W. (1989) Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res. 17, 3469-3478.
<https://doi.org/10.1093/nar/17.9.3469>
